Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Feb 24, 2017 · 10-K · 55 days after period end · 0001140361-17-009132
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$525.48K | -$2.85M | -$2.21M | -$2.72M |
| EPS Diluted | -$0.02 | -$0.02 | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Feb 24, 2017 · 55 d after period end
